Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6X2Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,492
Award facts
- Contract value 100% obligated
- $3,491.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,491.63 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector medication on January 16, 2026, with completion targeted for January 20, 2026. This is a firm fixed-price contract with no set-aside designation, awarded competitively to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
REPATHA is a specialty medication used for cholesterol management and cardiovascular disease prevention. This delivery order reflects routine pharmaceutical procurement through DLA's medical supply chain to support military treatment facilities and veteran healthcare programs. AmerisourceBergen, as a major pharmaceutical distributor, maintains the capability to fulfill federal medical supply needs through competitive procurement and has demonstrated versatility in delivering products across multiple therapeutic domains, from specialty medications to generic drugs and medical devices, making it a critical vendor for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F6X2Q?
SPE2DR26F6X2Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F6X2Q worth?
The government has obligated $3,492 on SPE2DR26F6X2Q.
Is contract SPE2DR26F6X2Q an order under another contract?
Yes. SPE2DR26F6X2Q is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6X2Q competed?
The extent of competition for SPE2DR26F6X2Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award